Effect of Biochanin A on Serum Nesfatin-1 Level in STZ Induced Type 1 Diabetic Rat
,
Abstract
Bioflavonoids such as biochanin A (BCA), exhibit insulin mimetic or secretagogues activities and are considered as hypoglycemic compounds. Nesfatin-1 is secreted from the hypothalamic nuclei and recognized as a regulatory peptide, which can increase insulin sensitivity and affect glucose metabolism. In this study, effects of BCA, on serum nesfatin-1 level were examined in rats with streptozotocin (STZ)-induced diabetes. We randomly divided 30 male Wistar rats into 2 control (6 rats per group) and 3 diabetic groups. Type I diabetes was induced using STZ (55 mg/kg bw) injection. Group 1 received 0.5% DMSO; while group 2 received 10 mg/kg body weight of BCA; group 3 (diabetic controls) received 0.5% DMSO; group 4, 10 mg/kg of BCA; and group 5, 15 mg/kg of BCA. The levels of serum insulin, nesfatin-1, and fasting blood glucose (FBG) were determined after 42 days. The serum insulin level increased; while FBG level significantly decreased in the BCA treatment groups. Both treatment groups had increased nesfatin-1 levels in comparison with the control groups; however, the difference was only significant in group 5 (p value < 0.05). Considering insulin and nesfatin-1 induction, BCA has potential hypoglycemic effects. Oral administration of 15 mg/kg BW of BCA showed greater efficacy than 10 mg/kg bw of BCA.
Association AD. Diagnosis and classification of diabetes mellitus. Diabetes care 2010;33:S62-S69.
Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sc 2013;9:191.
Oh S, Shimizu H, Satoh T, Okada S, Adachi S et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006;443:709.
Khalili S, Khaniani MS, Afkhami F, Derakhshan SM. NUCB2/Nesfatin-1: A Potent Meal Regulatory Hormone and its Role in Diabetes. Egypt J Med Hum Genet 2017;18:105-109.
Su Y, Zhang J, Tang Y, Bi F, Liu J-N. The novel function of nesfatin-1: anti-hyperglycemia. Biochemical and biophysical research communications. Biochem Biophys Res Commun 2010;391:1039-1042.
Nakata M, Manaka K, Yamamoto S, Mori M, Yada T. Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca2+ influx through L-type channels in mouse islet β-cells. Endocr J 2011;58:305-313.
Li Z, Gao L, Tang H, Yin Y, Xiang X et al. Peripheral effects of nesfatin-1 on glucose homeostasis. PLoS One 2013;8:e71513.
Schlyer S, Horuk R. I want a new drug: G-protein-coupled receptors in drug development. Drug Discov Today 2006;11:481-493.
Breikaa RM, Algandaby MM, El-Demerdash E, Abdel-Naim AB. Multimechanistic antifibrotic effect of biochanin a in rats: implications of proinflammatory and profibrogenic mediators. PLoS one 2013;8:e69276.
Harini R, Sundaresan A, Pugalendi K. Antihyperlipidemic effect of biochanin A on streptozotocin induced diabetic rats. J Pharm Res 2012;5:707-710.
Thiraphatthanavong P, Wattanathorn J, Muchimapura S, Thukham-mee W, Lertrat K, Suriharn B. The combined extract of purple waxy corn and ginger prevents cataractogenesis and retinopathy in streptozotocin-diabetic rats. Oxid Med Cell Longev 2014;2014:789406.
Harini R, Ezhumalai M, Pugalendi KV. Antihyperglycemic effect of biochanin A, a soy isoflavone, on streptozotocin-diabetic rats. Eur J Pharmacol 2012;676:89-94.
Azizi R, Goodarzi MT, Salemi Z. Effect of biochanin a on serum visfatin level of streptozocin-induced diabetic rats. Iran Red Crescent Med J 2014;16(9):e15424.
Wang L, Waltenberger B, Pferschy-Wenzig E-M, Blunder M, Liu X et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochem Pharmacol 2014;92:73-89.
Andallu B, Varadacharyulu NC. Antioxidant role of mulberry (Morus indica L. cv. Anantha) leaves in streptozotocin-diabetic rats. Clin Chim Acta 2003;338:3-10.
Kohno D, Nakata M, Maejima Y, Shimizu H, Sedbazar U et al. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology. 2008;149:1295-1301.
Li Q-C, Wang H-Y, Chen X, Guan H-Z, Jiang Z-Y. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 2010;159:72-77.
Diggs-Andrews KA, Zhang X, Song Z, Daphna-Iken D, Routh VH et al. Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia. Diabetes 2010;59:2271-2280.
Yamada M, Horiguchi K, Umezawa R, Hashimoto K, Satoh T et al. Troglitazone, a ligand of peroxisome proliferator-activated receptor-γ, stabilizes NUCB2 (nesfatin) mRNA by activating the ERK1/2 pathway: isolation and characterization of the human NUCB2 gene. Endocrinology 2010;151:2494-2503.
Mueller M, Jungbauer A. Red clover extract: a putative source for simultaneous treatment of menopausal disorders and the metabolic syndrome. Menopause 2008;15:1120-1131.
Mirzaei K, Hossein-nezhad A, Keshavarz SA, Koohdani F, Eshraghian MR et al. Association of nesfatin-1 level with body composition, dietary intake and resting metabolic rate in obese and morbid obese subjects. Diabetes Metab Syndr 2015;9:292-298.
| Files | ||
| Issue | Vol 6, No 2, 2021 | |
| Section | Research Article(s) | |
| DOI | https://doi.org/10.18502/tim.v6i2.6777 | |
| Keywords | ||
| Nesfatin-1 Biochanin A Diabetes Rat | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
